Palantir is priced like a perfect company, so even solid earnings that only meet expectations can send the stock falling.

We recently compiled a list of the 12 Best Growth Stocks to Buy and Hold for the Long Term. In this article, we are going to ...

The Dow opened lower after the Consumer Price Index report showed annual inflation slowed to 2.3%, marking the lowest inflation rate since early 2021. Follow along for live updates on the Dow, S&P 500 ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we ...

The trader was considering buying calls that expire on May 30, and he was looking to employ a $110 to $120 call spread ...

While Cisco's valuation never fully recovered, the company's current market cap of $236 billion is still far greater than it ...

In smaller transactions, ARK sold shares of Adaptive Biotechnologies Corp (NASDAQ: ADPT) and CareDx Inc (NASDAQ: CDNA ), and bought shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Veracyte Inc ...

Palantir remains a strong business with high profitability, but its current stock price makes it a "strong sell" for me. Your ...

We recently published a list of 11 Most Promising Future Stocks According to Hedge Funds. In this article, we are going to ...

PLTR Price Action: Palantir stock is down 14.1% to $106.30 on Tuesday versus a 52-week trading range of $63.40 to $125.41.

As of March, Palantir had nearly $1 billion in cash and $4.4 billion in marketable securities (mostly US Treasury securities) and no debt. Its liquidity position improved by $1.5 billion in 2024.